According to Janux Therapeutics's latest financial reports the company has โน56.68 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | โน28.63 B | 5.84% |
2022-12-31 | โน27.06 B | -3.04% |
2021-12-31 | โน27.90 B | 4784.37% |
2020-12-31 | โน0.57 B | 1117.74% |
2019-12-31 | โน46.92 M |